Firm of Choice
for the Most Difficult
Legal Issues


Cross-Border Capabilities
with a China Edge


Fangda advised Kangh in reaching an exclusive license agreement with HilleVax for the Recombinant Hexavalent VLP Norovirus Vaccine


Antitrust China Annual Review 2023
Our annual review examines ten significant trends in China's antitrust landscape in 2023 and presents the forecasts for 2024.

Awards & Rankings

The Legal 500 Asia-Pacific 2024
Tier 1 Rankings

Chambers Greater China Region Guide 2023
Band 1 Rankings